rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Sales 366.82 408.68 318.26 196.47 156.55
Operating profit 112.58 118.83 87.13 48.44 -153.04
Interest 6.20 13.11 15.21 10.13 11.88
Gross profit 106.38 105.72 71.92 38.31 -164.92
EPS (Rs) 1.75 1.64 1.44 1.03 -4.92
Annual  results in details
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Other income - - - - -
Stock adjustment 4.17 1.36 -1.84 9.19 10.33
Raw material 156.72 193.56 142.63 65.96 60.50
Power and fuel - - - - -
Employee expenses 26.13 23.66 21.39 15.39 13.55
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 67.22 71.28 68.95 57.48 225.20
Provisions made - - - - -
Depreciation 14.75 9.03 8.66 8.70 17.98
Taxation 20.14 29.58 7.70 -9.98 -1.84
Net profit / loss 71.49 67.11 55.56 39.58 -181.07
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 40.93 40.93 38.53 38.53 36.78
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - 2118.22 1878.15 1886.34 1898.24
Agg.of non promotoholding (%) - 51.75 48.75 48.96 51.61
OPM (%) 30.69 29.08 27.38 24.66 -97.76
GPM (%) - - - - -
NPM (%) - - - - -
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close